Health Sciences and Minimal Risk IRBs, IRB News / Volume 2, Number 2, February 2010
Beta testing of ARROW was successfully completed on February 19th. We want to thank all those members of the research community who generously volunteered their time to help test the system and provide us with very useful feedback.
ARROW is still expected to go live at the end of March with a small group of study teams representing the Cancer Center, Asthma/Allergy, and Radiology. Formal training of these study teams as well as IRB members will begin in late February and early March. A second phase of study teams will go live with system in early summer, with roll out expected to be complete by this fall.
Questions about ARROW?
The HS-IRBs Office has established a new email address for questions about ARROW: email@example.com. This email account is being monitored by IRB staff who are involved in the development of ARROW and thus able to answer any questions study teams might have about the new system. This email will continue to be used after ARROW is live to handle study team questions and system feedback.
The HS IRBs Office Is Moving!
On March 29-31, the HS-IRBs Office will move from its current location in the VA hospital to new space on the first floor of the University Bay Office Building, which is located at 800 University Bay Drive across from the VA hospital and UWHC. The IRB staff is working on ways to minimize the move’s impact on researchers, including setting up a drop box in space convenient to the UWHC and VA. Specifics about the move (including the move date and drop box location) will be provided soon, so please stay tuned for details. The IRB Office function may be affected during the three days needed to move office.
When To Close Protocols
In preparation for ARROW and the migration of study data for all open protocols with the IRB, we would like to remind investigators/research teams of the IRB guidance in regard to when a protocol should remain open with the IRB. IRB oversight of a research protocol is required as long as the activities conducted involve human subjects, such as collecting identifiable private information about individuals, including long-term follow-up or observation of subjects; or conducting data analysis of private information that is directly or indirectly identifiable. For multi-center studies, continuing review of the research by the UW-Madison IRB is no longer required after all human subject research activities have been completed by the UW researcher, even if (i) interactions or interventions with subject may be occurring at other sites; or (ii) data analysis of identifiable private information is ongoing at another central site that collects and analyzes data from all the study sites. Please take this opportunity to review your protocols accordingly to aid this transition to our fully electronic submission process, ARROW, for both the research community and the IRB.
Whether you have a question about a specific protocol, a general question about the submission process, or need clarification about research policy, we have several ways you can reach us.